Darvocet-N 50



Indications and Reactions:

Role Indications Reactions
Primary
Back Pain 33.3%
Myalgia 33.3%
Thermal Burn 33.3%
Abdominal Pain Upper 33.3%
Dizziness 33.3%
Hypertension 33.3%
Secondary
Pain In Extremity 26.1%
Pain 20.5%
Drug Use For Unknown Indication 8.0%
Back Pain 4.5%
Non-small Cell Lung Cancer Stage Iiib 4.5%
Agitation 3.4%
Depression 3.4%
Infection 3.4%
Osteoporosis 3.4%
Product Used For Unknown Indication 3.4%
Suicide Attempt 3.4%
Fibromyalgia 2.3%
Gastrooesophageal Reflux Disease 2.3%
Hypoaesthesia 2.3%
Multiple Sclerosis 2.3%
Peptic Ulcer 2.3%
Ankle Fracture 1.1%
Arthritis 1.1%
Blood Cholesterol Increased 1.1%
Burning Sensation 1.1%
Drug Hypersensitivity 11.1%
Alopecia 7.4%
Cardiac Arrest 7.4%
Hyponatraemia 7.4%
No Adverse Event 7.4%
Tremor 7.4%
Abdominal Pain 3.7%
Axillary Mass 3.7%
Completed Suicide 3.7%
Depression 3.7%
Hypersensitivity 3.7%
Medication Error 3.7%
Neuropathy Peripheral 3.7%
Pain 3.7%
Pleural Effusion 3.7%
Po2 Increased 3.7%
Postoperative Infection 3.7%
Pregnancy 3.7%
Pulmonary Oedema 3.7%
Rash 3.7%
Concomitant
Product Used For Unknown Indication 37.5%
Pain 13.0%
Multiple Myeloma 4.6%
Gastrooesophageal Reflux Disease 4.3%
Osteoporosis 4.3%
Breast Cancer Metastatic 3.9%
Arthritis 3.1%
Metastases To Bone 3.0%
Anxiety 3.0%
Depression 2.6%
Back Pain 2.5%
Rheumatoid Arthritis 2.5%
Hypertension 2.3%
Osteoarthritis 2.2%
Asthma 2.1%
Cough 2.1%
Contraception 2.0%
Migraine 1.8%
Neoplasm Malignant 1.7%
Acne 1.6%
Pain 11.8%
Pulmonary Embolism 8.9%
Myocardial Infarction 7.2%
Syncope 7.2%
Deep Vein Thrombosis 5.9%
Oedema Peripheral 5.9%
Heart Valve Calcification 5.5%
Radiotherapy 5.5%
Injury 5.1%
Vomiting 5.1%
Dyspnoea 4.6%
Back Pain 3.8%
Death 3.4%
Urinary Tract Infection 3.4%
Abdominal Pain 3.0%
Abdominal Pain Upper 3.0%
Ventricular Extrasystoles 3.0%
Weight Decreased 3.0%
Aortic Aneurysm 2.5%
Arthritis 2.5%